We recently showed that the mechanism by which GFI1 enhanced MM viability in MM cells independently of p53 status is by repression of the SGPP1 gene and protein, and indirect promotion of activated SphK1 protein, together resulting in increased intracellular S1P levels in the MM cells (36). This evidence concerns the gene TP53 and Miyoshi myopathy.